Business
License & Product Supply Agreement with Byotrol
License & Product Supply Agreement with Byotrol.
About this update from Tristel Plc
[{"type":"text","content":"\n \n \n RNS Number : 1028H\n Tristel PLC\n 23 March 2020\n \n \n \n \n TRISTEL plc\n (\"Tristel\" or the \"Company\")\n \n Know-How License and Product Supply Agreement with\n Byotrol plc (\"Byotrol\")\n \n Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products announces that it has entered into a know-how licence and commercial collaboration with Byotrol (\"Agreement\"). The Agreement relates to the joint development of a biocidal formulation and Byotrol's development of two additional biocidal products and formulations that will be supplied and licensed to Tristel. \n \n Jointly developed formulation\n This formulation will create a unique surface disinfectant product for hospitals by combining the two companies' core technologies. \n \n The formulation combines Tristel's chlorine dioxide chemistry, which is sporicidal meaning that it has the highest level of disinfection efficacy, with ACTIZONE, a Solvay S.A. technology developed in collaboration with Byotrol and which enables a disinfectant to have long-lasting efficacy on a surface for an 8-hour period after first application. Tristel will incorporate the jointly developed formulation in several packaging formats under the family name \"Tristel8\". These products will be unique worldwide in combining sporicidal efficacy with residual disinfection efficacy.\n \n Additional biocidal products\n In addition, Byotrol will licence two biocidal formulations to Tristel for incorporation in its surface disinfectants range which is branded Cache. Cache represents a novel approach to today's very relevant issues of hospital hygiene and environmental concern. \n \n The Byotrol products and formulations give Tristel access to intermediate level disinfectants that are effective against bacteria, viruses and yeasts in accordance with the requirements of European Test Norms. The disinfectants will be for use in hospitals and will conform with the requirements of the European Biocidal Products Registration (BPR), and the United Kingdom equivalent that will come into force post Brexit. As this legislation is implemented throughout the United Kingdom and Europe during the coming years various active ingredients that are commonly incorporated in hosp...